Logo image of STAA

STAAR SURGICAL CO (STAA) Stock Fundamental Analysis

NASDAQ:STAA - Nasdaq - US8523123052 - Common Stock - Currency: USD

17.24  -0.14 (-0.81%)

Fundamental Rating

4

Overall STAA gets a fundamental rating of 4 out of 10. We evaluated STAA against 187 industry peers in the Health Care Equipment & Supplies industry. STAA has a great financial health rating, but its profitability evaluates not so good. STAA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year STAA has reported negative net income.
In the past year STAA has reported a negative cash flow from operations.
Of the past 5 years STAA 4 years were profitable.
Each year in the past 5 years STAA had a positive operating cash flow.
STAA Yearly Net Income VS EBIT VS OCF VS FCFSTAA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

With a Return On Assets value of -15.54%, STAA perfoms like the industry average, outperforming 54.01% of the companies in the same industry.
The Return On Equity of STAA (-20.31%) is better than 60.96% of its industry peers.
Industry RankSector Rank
ROA -15.54%
ROE -20.31%
ROIC N/A
ROA(3y)3.25%
ROA(5y)3.83%
ROE(3y)4.04%
ROE(5y)4.92%
ROIC(3y)N/A
ROIC(5y)N/A
STAA Yearly ROA, ROE, ROICSTAA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

STAA has a better Gross Margin (74.00%) than 86.10% of its industry peers.
STAA's Gross Margin has been stable in the last couple of years.
STAA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5Y0.47%
STAA Yearly Profit, Operating, Gross MarginsSTAA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

STAA does not have a ROIC to compare to the WACC, probably because it is not profitable.
STAA has more shares outstanding than it did 1 year ago.
STAA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, STAA has an improved debt to assets ratio.
STAA Yearly Shares OutstandingSTAA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
STAA Yearly Total Debt VS Total AssetsSTAA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 5.40 indicates that STAA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.40, STAA is in the better half of the industry, outperforming 78.61% of the companies in the same industry.
STAA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.4
ROIC/WACCN/A
WACC9.08%
STAA Yearly LT Debt VS Equity VS FCFSTAA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

STAA has a Current Ratio of 4.78. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
STAA has a better Current ratio (4.78) than 72.19% of its industry peers.
STAA has a Quick Ratio of 4.07. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of STAA (4.07) is better than 74.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 4.07
STAA Yearly Current Assets VS Current LiabilitesSTAA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for STAA have decreased strongly by -145.31% in the last year.
STAA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.49% yearly.
The Revenue for STAA has decreased by -14.44% in the past year. This is quite bad
STAA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.88% yearly.
EPS 1Y (TTM)-145.31%
EPS 3Y-12.35%
EPS 5Y7.49%
EPS Q2Q%-688.89%
Revenue 1Y (TTM)-14.44%
Revenue growth 3Y10.84%
Revenue growth 5Y15.88%
Sales Q2Q%-44.94%

3.2 Future

The Earnings Per Share is expected to grow by 22.71% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.19% on average over the next years.
EPS Next Y-634.34%
EPS Next 2Y-56.85%
EPS Next 3Y4.01%
EPS Next 5Y22.71%
Revenue Next Year-25.44%
Revenue Next 2Y-2.37%
Revenue Next 3Y1.07%
Revenue Next 5Y5.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STAA Yearly Revenue VS EstimatesSTAA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
STAA Yearly EPS VS EstimatesSTAA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

STAA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STAA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STAA Price Earnings VS Forward Price EarningsSTAA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STAA Per share dataSTAA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-56.85%
EPS Next 3Y4.01%

More info and screens

0

5. Dividend

5.1 Amount

STAA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STAAR SURGICAL CO

NASDAQ:STAA (7/14/2025, 10:09:56 AM)

17.24

-0.14 (-0.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners109.32%
Inst Owner Change0%
Ins Owners0.38%
Ins Owner Change18.46%
Market Cap853.90M
Analysts71.58
Price Target22.59 (31.03%)
Short Float %13.3%
Short Ratio7.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1693.07%
Min EPS beat(2)-3398.76%
Max EPS beat(2)12.63%
EPS beat(4)3
Avg EPS beat(4)-804.54%
Min EPS beat(4)-3398.76%
Max EPS beat(4)120.44%
EPS beat(8)5
Avg EPS beat(8)-392.44%
EPS beat(12)9
Avg EPS beat(12)-233.83%
EPS beat(16)12
Avg EPS beat(16)-144.65%
Revenue beat(2)1
Avg Revenue beat(2)-17.15%
Min Revenue beat(2)-37.91%
Max Revenue beat(2)3.61%
Revenue beat(4)2
Avg Revenue beat(4)-8.1%
Min Revenue beat(4)-37.91%
Max Revenue beat(4)3.61%
Revenue beat(8)3
Avg Revenue beat(8)-4.68%
Revenue beat(12)4
Avg Revenue beat(12)-2.78%
Revenue beat(16)6
Avg Revenue beat(16)-1.16%
PT rev (1m)0%
PT rev (3m)0.39%
EPS NQ rev (1m)-0.35%
EPS NQ rev (3m)-15.23%
EPS NY rev (1m)-5.57%
EPS NY rev (3m)-95.69%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.03%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.06
P/FCF N/A
P/OCF N/A
P/B 2.44
P/tB 2.45
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS5.64
BVpS7.07
TBVpS7.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.54%
ROE -20.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74%
FCFM N/A
ROA(3y)3.25%
ROA(5y)3.83%
ROE(3y)4.04%
ROE(5y)4.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5Y0.47%
F-Score2
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 246.03%
Cap/Sales 7.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.78
Quick Ratio 4.07
Altman-Z 5.4
F-Score2
WACC9.08%
ROIC/WACCN/A
Cap/Depr(3y)365.33%
Cap/Depr(5y)348.39%
Cap/Sales(3y)6.49%
Cap/Sales(5y)6.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.31%
EPS 3Y-12.35%
EPS 5Y7.49%
EPS Q2Q%-688.89%
EPS Next Y-634.34%
EPS Next 2Y-56.85%
EPS Next 3Y4.01%
EPS Next 5Y22.71%
Revenue 1Y (TTM)-14.44%
Revenue growth 3Y10.84%
Revenue growth 5Y15.88%
Sales Q2Q%-44.94%
Revenue Next Year-25.44%
Revenue Next 2Y-2.37%
Revenue Next 3Y1.07%
Revenue Next 5Y5.19%
EBIT growth 1Y-295.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-543.45%
EBIT Next 3Y80.58%
EBIT Next 5Y67.76%
FCF growth 1Y-286.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-133.17%
OCF growth 3Y-29.01%
OCF growth 5Y-9.43%